Literature DB >> 3253424

The nature of the presynaptic effects of (+)-tubocurarine at the mouse neuromuscular junction.

C B Ferry1, S S Kelly.   

Abstract

1. The effects of (+)-tubocurarine (TC) on tetanic run-down and quantum content of end-plate potentials (EPPs) were investigated in cut-fibre preparations of mouse diaphragm. 2. (+)-Tubocurarine, 0.15 microM, halved the amplitude of spontaneous miniature EPPs (MEPPs) and steepened the tetanic run-down of EPPs evoked at 10 Hz by increasing the quantum content of the first EPP of the train while having no effect on quantum content of plateau EPPs. With stimulation at 1 Hz, there was little run-down and the quantum content of all EPPs was increased by TC. 3. The use of binomial statistics to analyse release indicated that after TC the increase in the quantum content of the first EPP in the train at 10 Hz was due to an increase in n and that during the run-down there was a decrease in p so that plateau EPP quantum content at 10 Hz was not different from control. 4. To elucidate a possible role of cholinoreceptors in the presynaptic effects of TC, studies were made on the effects of pancuronium or of alpha-bungarotoxin (BTX), with concentrations and exposure times where they had postsynaptic effects equal to 0.15 microM-TC. The run-down of EPPs was unaffected by BTX, while pancuronium steepened it to a lesser extent than TC. 5. The anticholinesterase, ecothiopate, decreased the quantum content of plateau EPPs only at high frequencies of stimulation (50 Hz) and did not affect the presynaptic effects of TC at 10 Hz. 6. At concentrations which reduced MEPP amplitude, atropine (10 microM) or hexamethonium (50 microM) had no effect on EPP run-down. 7. These results indicate that TC could have presynaptic effects via a presynaptic acetylcholine receptor, but that such a receptor may not have the same binding specificities as the postsynaptic receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3253424      PMCID: PMC1190721          DOI: 10.1113/jphysiol.1988.sp017257

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  23 in total

1.  Presynaptic action of curare.

Authors:  M I Glavinović
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

2.  The effect of age on neuromuscular transmission.

Authors:  S S Kelly
Journal:  J Physiol       Date:  1978-01       Impact factor: 5.182

Review 3.  The actions of cholinergic drugs on motor nerve terminals.

Authors:  M D Miyamoto
Journal:  Pharmacol Rev       Date:  1977-09       Impact factor: 25.468

4.  Cytochemical localization of acetylcholine receptors at the neuromuscular junction by means of horseradish peroxidase-labeled alpha-bungarotoxin.

Authors:  T L Lentz; J E Mazurkiewicz; J Rosenthal
Journal:  Brain Res       Date:  1977-09-02       Impact factor: 3.252

5.  Non-linear summation of end-plate potentials in the frog and mouse.

Authors:  E M McLachlan; A R Martin
Journal:  J Physiol       Date:  1981-02       Impact factor: 5.182

6.  Influence of presynaptic receptors on neuromuscular transmission in rat.

Authors:  D F Wilson
Journal:  Am J Physiol       Date:  1982-05

7.  Is an acetylcholine transport system responsible for nonquantal release of acetylcholine at the rodent myoneural junction?

Authors:  C Edwards; V Dolezal; S Tucek; H Zemková; F Vyskocil
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm.

Authors:  C C Chang; S J Hong; J L Ko
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

9.  Neuromuscular transmission and correlative morphology in young and old mice.

Authors:  B Q Banker; S S Kelly; N Robbins
Journal:  J Physiol       Date:  1983-06       Impact factor: 5.182

10.  The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog.

Authors:  K L Magleby; B S Pallotta; D A Terrar
Journal:  J Physiol       Date:  1981-03       Impact factor: 5.182

View more
  8 in total

1.  Synaptic vesicle dynamics in rat fast and slow motor nerve terminals.

Authors:  B Reid; C R Slater; G S Bewick
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves.

Authors:  L Zhou; C L Zhang; A Messing; S Y Chiu
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

3.  Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.

Authors:  S J Hong; C C Chang
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

4.  Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction.

Authors:  Véronique Bernard; Emmanuelle Girard; Anna Hrabovska; Shelley Camp; Palmer Taylor; Benoit Plaud; Eric Krejci
Journal:  Mol Cell Neurosci       Date:  2010-09-29       Impact factor: 4.314

5.  The effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles.

Authors:  S S Kelly; C B Ferry; J P Bamforth
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

6.  The origin of the effects of an anticholinesterase on the latencies of action potentials in mouse skeletal muscles.

Authors:  S S Kelly; C B Ferry
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

7.  Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.

Authors:  L Tian; C Prior; J Dempster; I G Marshall
Journal:  J Physiol       Date:  1994-05-01       Impact factor: 5.182

8.  Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology.

Authors:  Noa Farchi; Hermona Soreq; Binyamin Hochner
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.